CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,241,708
- in 3 filings, $108K under 10b5-1 plans
Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-27 | Schechter Adam H President & CEO | Grant or award | +30,469 | 118,651 | ||
| 2025-03-27 | Schechter Adam H President & CEO | Shares withheld for taxes | −13,584 | $231.67 | $3.1M | 105,067 |
| 2025-03-27 | EISENBERG GLENN A Executive Vice President | Grant or award | +8,305 | 41,550 | ||
| 2025-03-27 | EISENBERG GLENN A Executive Vice President | Shares withheld for taxes | −3,630 | $231.67 | $841K | 37,920 |
| 2025-03-27 | BERBERIAN LANCE EVP, Special Advisor, Strategy | Grant or award | +3,325 | 20,005 | ||
| 2025-03-27 | BERBERIAN LANCE EVP, Special Advisor, Strategy | Shares withheld for taxes | −1,353 | $231.67 | $313K | 18,652 |
| 2025-03-27 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Grant or award | +4,840 | 34,175.66 | ||
| 2025-03-27 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Shares withheld for taxes | −2,109 | $231.67 | $489K | 32,066.66 |
| 2025-03-27 | Wilkinson Peter J SVP, Chief Accounting Officer | Grant or award | +1,249 | 3,242.22 | ||
| 2025-03-27 | Wilkinson Peter J SVP, Chief Accounting Officer | Shares withheld for taxes | −359 | $231.67 | $83K | 2,883.22 |
| 2025-03-27 | Oyegunwa Akinbolade EVP, CIO & CTO | Grant or award | +688 | 3,662.25 | ||
| 2025-03-27 | Oyegunwa Akinbolade EVP, CIO & CTO | Shares withheld for taxes | −198 | $231.67 | $46K | 3,464.25 |
| 2025-03-05 | ANDERSON KERRII B Director | Sale | −500 | $255.63 | $128K | 13,166 |
| 2025-02-28 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise 10b5-1 | +3,903 | $131.43 | $513K | 10,299.14 |
| 2025-02-28 | Schroeder Mark S EVP, Pres Diagnostics & COO | Sale 10b5-1 | −5,339 | $249.23 | $1.3M | 4,960.14 |
| 2025-02-28 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise · Non-qualified Stock Options 10b5-1 | −3,903 | 0 | ||
| 2025-02-25 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale | −1,314 | $251.30 | $330K | 2,170.54 |
| 2025-02-24 | Summy Amy B. EVP, Chief Marketing Officer | Sale 10b5-1 | −226 | $250.40 | $57K | 4,544.5 |
| 2025-02-18 | Wilkinson Peter J SVP, Chief Accounting Officer | Option exercise | +1,413 | $163.63 | $231K | 3,406.22 |
| 2025-02-18 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −1,413 | $246.10 | $348K | 1,993.22 |
Page 15 of 28 · 545 trades